Treatment Delays in the Hispanic Population with Renal Cell Carcinoma: An Analysis of Over 150,000 Patients using the National Cancer Database.

IF 0.8 Q4 UROLOGY & NEPHROLOGY Urology Practice Pub Date : 2025-03-14 DOI:10.1097/UPJ.0000000000000801
Vatsala Mundra, Zachary Melchiode, Jiaqiong Xu, Carlos Riveros, Raj Satkunasivam, Christopher J D Wallis, Dharam Kaushik
{"title":"Treatment Delays in the Hispanic Population with Renal Cell Carcinoma: An Analysis of Over 150,000 Patients using the National Cancer Database.","authors":"Vatsala Mundra, Zachary Melchiode, Jiaqiong Xu, Carlos Riveros, Raj Satkunasivam, Christopher J D Wallis, Dharam Kaushik","doi":"10.1097/UPJ.0000000000000801","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Disparities have been documented in the outcomes of various cancers (lung, colorectal, breast) among the Hispanic population compared to non-Hispanic whites (NHWs). However, little is known about disparities in renal cell carcinoma (RCC) management despite worse outcomes for those with delays in treatment. This study aimed to investigate the disparities in 1) RCC presentation and 2) the time to treatment initiation (TTI) between Hispanic and NHW patients.</p><p><strong>Patients & methods: </strong>We conducted a comparative analysis using National Cancer Database data from 2004-2020 to evaluate disparities in RCC presentation and TTI between Hispanic and NHW patients. To minimize inherent differences between the two groups, we utilized 1:1 greedy caliper propensity score matching.</p><p><strong>Results: </strong>After PSM, we analyzed a cohort of 7798 Hispanic and NHW patients. Hispanic patients had an increased likelihood of presenting with clinical T2b RCC relative to NHW patients (odds ratio [OR] 1.28; 95% confidence interval [CI] 1.03, 1.60) and were more likely to experience delays in surgery (hazard ratio [HR] 1.08; 95% CI 1.01, 1.16; p=0.017) or any other treatment (HR 1.08; 95% CI 1.01, 1.16; p=0.022). Hispanic patients also received chemotherapy later (HR 1.49; 95% CI 1.05, 2.12; p=0.027).</p><p><strong>Conclusions: </strong>Our data indicate that Hispanic patients often present with more advanced stages of RCC and are likely to experience delays in treatment. This study underscores significant disparities in the presentation and care of RCC between Hispanic and NHWs, highlighting the need for targeted interventions to address these inequalities.</p>","PeriodicalId":45220,"journal":{"name":"Urology Practice","volume":" ","pages":"101097UPJ0000000000000801"},"PeriodicalIF":0.8000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/UPJ.0000000000000801","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Disparities have been documented in the outcomes of various cancers (lung, colorectal, breast) among the Hispanic population compared to non-Hispanic whites (NHWs). However, little is known about disparities in renal cell carcinoma (RCC) management despite worse outcomes for those with delays in treatment. This study aimed to investigate the disparities in 1) RCC presentation and 2) the time to treatment initiation (TTI) between Hispanic and NHW patients.

Patients & methods: We conducted a comparative analysis using National Cancer Database data from 2004-2020 to evaluate disparities in RCC presentation and TTI between Hispanic and NHW patients. To minimize inherent differences between the two groups, we utilized 1:1 greedy caliper propensity score matching.

Results: After PSM, we analyzed a cohort of 7798 Hispanic and NHW patients. Hispanic patients had an increased likelihood of presenting with clinical T2b RCC relative to NHW patients (odds ratio [OR] 1.28; 95% confidence interval [CI] 1.03, 1.60) and were more likely to experience delays in surgery (hazard ratio [HR] 1.08; 95% CI 1.01, 1.16; p=0.017) or any other treatment (HR 1.08; 95% CI 1.01, 1.16; p=0.022). Hispanic patients also received chemotherapy later (HR 1.49; 95% CI 1.05, 2.12; p=0.027).

Conclusions: Our data indicate that Hispanic patients often present with more advanced stages of RCC and are likely to experience delays in treatment. This study underscores significant disparities in the presentation and care of RCC between Hispanic and NHWs, highlighting the need for targeted interventions to address these inequalities.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
Urology Practice
Urology Practice UROLOGY & NEPHROLOGY-
CiteScore
1.80
自引率
12.50%
发文量
163
期刊最新文献
Treatment Delays in the Hispanic Population with Renal Cell Carcinoma: An Analysis of Over 150,000 Patients using the National Cancer Database. Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases. Changes in Vasectomy Practice Patterns After-Dobbs: A Multi-Institutional Study. Neoadjuvant Chemotherapy and Partial Cystectomy for Muscle-Invasive Bladder Cancer - 20-year bladder-preserved survival. Use and Usefulness of Risk Prediction Tools in Urologic Surgery: Current State and Path Forward.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1